Provided by Tiger Trade Technology Pte. Ltd.

Credit Suisse Holdings

2,469.81
+26.231.07%
Number of Gainers:54
Number of Losers:41
Number of Flat:2
PE:- -
High:2,480.54
Open:2,443.77
Low:2,443.77
Close:2,443.58
Volume:1.44B
Turnover:296.38B
Market Cap:51.71T
Float Cap:48.39T

Loading ...

Oil Rises as Supply Concerns Persist Despite Middle East Crude Exports Recovering to Prewar Levels

Dow Jones
·
Oct 01

This Fidelity Manager Likes Coca-Cola, Keurig Dr Pepper, and Other Consumer Staples Bargains

Dow Jones
·
Oct 01

X-Rite Pantone Launches Spectura Portable Sphere Spectrophotometer Platform

Reuters
·
Oct 01

India's CAFE 3 Norms Favour EV Suppliers, Ease Compliance Burden for OEMs, Say BofA, Nomura

Reuters
·
Oct 01

Citi Raises Bitcoin, Ether Forecasts on Strong Crypto Activity

Reuters
·
Oct 01

Thales - Thales and Google Strengthen Their Partnership to Secure Agent-Based AI

THOMSON REUTERS
·
Oct 01

Tesla New Registrations in Sweden +38.4% Year-on-Year in September, Compiler Mobility Sweden Says

THOMSON REUTERS
·
Oct 01

Nippon Prologis REIT Advances Unit Buybacks Under ¥10 Billion Program

TIPRANKS
·
Oct 01

Piper Sandler Raises Microsoft Price Target to $610, Citing Copilot and E7 as New M365 Monetization Drivers

Deep News
·
Oct 01

Goldman Sachs pushes back second Fed rate hike forecast to December, saying need for further tightening is diminishing

Deep News
·
Oct 01

Barclays (BARC) Gets a Buy from J.P. Morgan

TIPRANKS
·
Oct 01

Bayer Names Christoph Koenen Chief Medical Officer

Reuters
·
Oct 01

Pfizer Says Tilrekimig Hits Phase 2 Atopic Dermatitis Endpoint with 62.5% EASI-75 at Week 16

Reuters
·
Oct 01

Pfizer - no Serious Adverse Events Related to Tilrekimig in Phase 2 Study

THOMSON REUTERS
·
Oct 01

Pfizer's Tilrekimig Shows Significant Skin Clearance in Phase 2 Atopic Dermatitis Study

THOMSON REUTERS
·
Oct 01

Pfizer - Tilrekimig Well-Tolerated with Teae Rates Comparable to Placebo

THOMSON REUTERS
·
Oct 01

Pfizer - 62.5% of Patients on Tilrekimig 450 Mg Q2w Achieve Easi-75 vs 19.9% Placebo

THOMSON REUTERS
·
Oct 01

Pfizer - Phase 2 Study Meets Primary Endpoint with Significant Easi-75 Improvement at Week 16

THOMSON REUTERS
·
Oct 01

Starz Entertainment Corp. - Customers Lose Access After Failed Negotiations with Verizon

THOMSON REUTERS
·
Oct 01

Top 3 Founder Run Stocks To Watch In October 2026

Simply Wall St.
·
Oct 01